From: The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
Her2 non-amplification | Her2 amplification | Total | |
---|---|---|---|
n (%) | n (%) | n (%) | |
Kras wild type | 3 (14.29) | 5 (23.81) | 8 (38.10) |
Kras mutation | 11 (52.38) | 2 (9.52) | 13 (61.90) |
Total | 14 (66.67) | 7 (33.33) | 21 (100.00) |
P value | 0.056a |